These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6416134)

  • 1. [Percutaneous nitroglycerin and its indications in intensive care. Apropos of 10 cases].
    Moine M
    Ann Cardiol Angeiol (Paris); 1983; 32(2):127-33. PubMed ID: 6416134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of the intravenous nitroglycerin dose on the appearance of drug tolerance].
    Barranco F; Lesmes A; Irles J; Peñas L; Schiaffino S; Ballesteros J; Pomares J
    Med Clin (Barc); 1995 Mar; 104(11):407-10. PubMed ID: 7715258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nitroglycerin ointment.
    Elliott WC
    J Indiana State Med Assoc; 1974 Feb; 67(2):99-103. PubMed ID: 4204690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of intravenous administration of nitroglycerin on the indicators of central hemodynamics in patients with acute myocardial infarction].
    Afonskaia NI; Ostrogorskiĭ IuM; Karpov IuA; Ivanishvili LO; Iasinovskiĭ VD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):49-54. PubMed ID: 6416267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of a nitroglycerin ointment on myocardial ischemic injury].
    Hayashi H; Kojima H; Takami K; Uematsu H; Ishikawa T; Sotobata I; Hasegawa S; Samoto T; Itoh T
    Kokyu To Junkan; 1982 Sep; 30(9):945-52. PubMed ID: 6817400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolonged hemodynamic effects of nitroglycerin ointment in acute myocardial infarction (author's transl)].
    Previtali M; Medici A; Chimient M; Salerno JA; Bobba P
    G Ital Cardiol; 1981; 11(6):768-75. PubMed ID: 6797859
    [No Abstract]   [Full Text] [Related]  

  • 7. [Venous use of nitroglycerin in acute myocardial infarct].
    Terzieva L
    Vutr Boles; 1984; 23(6):8-13. PubMed ID: 6442491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of central venous catheter in cardiologic intensive care].
    Tot L; Ognjanović D; Trifunović S; Stojsić Dj; Kovać M
    Med Pregl; 1978; 31(3-4):107-11. PubMed ID: 672786
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of left ventricular insufficiency with percutaneous trinitrin].
    Lancelin B; Vahanian A; Lecannelier E; Dubois C; Bonin M; Rolland E; Pornin P; Guermonprez JL; Maurice P
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1163-70. PubMed ID: 6778408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion].
    Djonlagic H; Funke K; Lessmann J; Nitsche K; Kreymann G; Lipke M; Fuchs M
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():10-6. PubMed ID: 7968893
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood glucose in the acute phase of myocardial infarction treated with nitroglycerin or heparin].
    Klimek K; Gregorczyk J; Olejak B; Dutkiewicz-Seredyńska G; Chełstowski K
    Przegl Lek; 1988; 45(2):269-72. PubMed ID: 3136514
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of central venous pressure--experiences of an internal medicine intensive care unit].
    Fleischmann J; Köhler H; Engelmann L
    Z Gesamte Inn Med; 1972 Mar; 27(5):202-7. PubMed ID: 5049354
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous nitroglycerin in acute coronary artery disease.
    Marrott PK; Nairn PL; Dawson CJ; Martin SM
    N Z Med J; 1982 Sep; 95(716):663-6. PubMed ID: 6813780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of left ventricular failure with percutaneous nitroglycerin (author's transl)].
    Lancelin B; Guermonprez JL; Bonin M; Maurice P
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2478-82. PubMed ID: 6775302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous nitroglycerin therapy on infarct size in patients with acute myocardial infarction.
    Raos V; Jeren-Strujić B; Ljutić D; Horvatin-Godler S; Straus B
    Acta Med Croatica; 1995; 49(1):5-14. PubMed ID: 7633178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ageusia associated with transdermal nitroglycerin.
    Ewing RC; Janda SM; Henann NE
    Clin Pharm; 1989 Feb; 8(2):146-7. PubMed ID: 2492914
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with intravenous infusion of nitroglycerin in myocardial infarction and acute coronary failure].
    Aleksandrow D; Aleksandrow W; Dyduszyński A; Wiernikowski A
    Kardiol Pol; 1982; 25(10-11):821-8. PubMed ID: 6820808
    [No Abstract]   [Full Text] [Related]  

  • 19. IV nitroglycerin: reducing complications at high dosages (continuing education credit).
    Carlson S; Zell C
    Dimens Crit Care Nurs; 1988; 7(2):83-90. PubMed ID: 3128434
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of topical and oral slow-release nitroglycerin on anterior myocardial infarction size assessed by precordial ST segment mapping.
    Horgan JH; Teo KK; Moody JW
    Eur J Cardiol; 1980; 11(5):387-96. PubMed ID: 6772449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.